Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03065400
Title PD-1 Inhibition in Advanced Myeloproliferative Neoplasms
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors John Mascarenhas
Indications

myelofibrosis

essential thrombocythemia

bone marrow cancer

Therapies

Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Harvard Medical School Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Montefiore Medical Center Division of Hematology, Department of Oncology Bronx New York 10467 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field